The research had begun on April 28th of 2011 when it had received clearance from United States Food and Drug Administration and is currently ongoing. They have taken patients over 18 years old with diagnosed advanced Stargardt’s disease and with visual acuity lower than 20/400 for the worse vision research and 20/100 for higher vision research. They currently have 16 research subjects, undergoing the transplantation of the stem cells into the mascular tissue. They have split the 16 subjects into 5 groups; four groups have low vision (vision worse than 20/400) and have transplanted a range of 50,000 stem cells to 200,000 stem cells with increasing 50,000 intervals between each group. There is currently one group with better vision and 100,000 of the same stem cells have been transplanted into the
The research had begun on April 28th of 2011 when it had received clearance from United States Food and Drug Administration and is currently ongoing. They have taken patients over 18 years old with diagnosed advanced Stargardt’s disease and with visual acuity lower than 20/400 for the worse vision research and 20/100 for higher vision research. They currently have 16 research subjects, undergoing the transplantation of the stem cells into the mascular tissue. They have split the 16 subjects into 5 groups; four groups have low vision (vision worse than 20/400) and have transplanted a range of 50,000 stem cells to 200,000 stem cells with increasing 50,000 intervals between each group. There is currently one group with better vision and 100,000 of the same stem cells have been transplanted into the